Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Clinical benefit of front-loaded tPA over combination thrombolytic therapy or APSAC for acute MI: results of the TIMI 4 trial

Cannon CP, McCabe CH, Diver DJ, Herson S, Green RM, Shah PK, Sequeira RF, Leya F, Kirshenbaum JM, Magorien RD, Palmeri S, Dangoisse V, Flaker GC, Davis V, Chaitman B, Wackers FJT, Zaret BL, Gibson CM, Poole WK, Braunwald E, for the TIMI 4 Investigators. Clinical benefit of front-loaded tPA over combination thrombolytic therapy or APSAC for acute MI: results of the TIMI 4 trial. Circulation. 1993; 88:1-291.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.